乌鸦传媒

Clinical trials of xenotransplantation expected to kick off next year

Anti-mineralocorticoid agent reduced albuminuria, but not eGFR-based kidney outcome

Deaths more common in male donors and those with history of hypertension

Staves off end-stage renal disease, retrospective study indicates

Kidney transplants did not increase either

Those with higher lead levels in household drinking water more likely to need maximum ESA dosing

But results were not fully durable after treatment cessation

Risk for delayed graft function higher, but other endpoints no different

Risk was significantly higher regardless of dialysis status

Most scripts originated from clinicians other than nephrologists

Surgery marks sixth human xenotransplant performed at NYU Langone Health

Intervention "did not overcome barriers" to PCP, patient behavior changes, editorialists say

Indication for HIF-PH inhibitor vadadustat limited to patients already on dialysis